Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hippocampus | 14 | 2017 | 273 | 2.010 |
Why?
|
| Magnetic Resonance Imaging | 17 | 2023 | 1112 | 1.110 |
Why?
|
| Epilepsy, Temporal Lobe | 5 | 2023 | 22 | 1.080 |
Why?
|
| Electroencephalography | 4 | 2024 | 77 | 1.040 |
Why?
|
| Entorhinal Cortex | 8 | 2012 | 37 | 0.910 |
Why?
|
| Alzheimer Disease | 11 | 2019 | 2109 | 0.780 |
Why?
|
| Memory Disorders | 3 | 2017 | 159 | 0.690 |
Why?
|
| Atrophy | 8 | 2014 | 91 | 0.660 |
Why?
|
| Memory | 6 | 2012 | 297 | 0.590 |
Why?
|
| Temporal Lobe | 4 | 2023 | 83 | 0.560 |
Why?
|
| Neural Pathways | 1 | 2017 | 63 | 0.550 |
Why?
|
| Nerve Fibers, Myelinated | 3 | 2012 | 28 | 0.540 |
Why?
|
| Epilepsy | 3 | 2018 | 60 | 0.400 |
Why?
|
| White Matter | 1 | 2014 | 134 | 0.390 |
Why?
|
| Parahippocampal Gyrus | 2 | 2011 | 7 | 0.380 |
Why?
|
| Amnesia | 2 | 2011 | 24 | 0.350 |
Why?
|
| Drug Resistant Epilepsy | 2 | 2023 | 10 | 0.340 |
Why?
|
| Brain Mapping | 5 | 2016 | 147 | 0.330 |
Why?
|
| Cerebral Cortex | 3 | 2017 | 155 | 0.330 |
Why?
|
| Aging | 6 | 2018 | 1544 | 0.310 |
Why?
|
| Organ Size | 7 | 2014 | 95 | 0.300 |
Why?
|
| Female | 23 | 2018 | 15212 | 0.300 |
Why?
|
| Humans | 27 | 2024 | 27072 | 0.290 |
Why?
|
| Male | 20 | 2018 | 14772 | 0.280 |
Why?
|
| Nerve Fibers | 1 | 2006 | 12 | 0.260 |
Why?
|
| Aged | 17 | 2018 | 8997 | 0.260 |
Why?
|
| Predictive Value of Tests | 6 | 2016 | 474 | 0.200 |
Why?
|
| Aged, 80 and over | 8 | 2012 | 4777 | 0.200 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 3 | 2018 | 10 | 0.200 |
Why?
|
| Perforant Pathway | 2 | 2012 | 4 | 0.200 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 2 | 2012 | 4 | 0.190 |
Why?
|
| Potassium Channels | 2 | 2012 | 38 | 0.190 |
Why?
|
| Cohort Studies | 4 | 2018 | 1890 | 0.180 |
Why?
|
| Neuroimaging | 3 | 2018 | 126 | 0.180 |
Why?
|
| Membrane Proteins | 2 | 2012 | 165 | 0.170 |
Why?
|
| Longitudinal Studies | 3 | 2011 | 1368 | 0.170 |
Why?
|
| Disease Progression | 5 | 2012 | 673 | 0.160 |
Why?
|
| Adult | 8 | 2017 | 7831 | 0.160 |
Why?
|
| Neurology | 1 | 2019 | 37 | 0.150 |
Why?
|
| Channelopathies | 1 | 2018 | 5 | 0.150 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2018 | 8 | 0.150 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 44 | 0.150 |
Why?
|
| Pyramidal Cells | 1 | 2018 | 34 | 0.150 |
Why?
|
| Neuronal Plasticity | 1 | 2018 | 47 | 0.150 |
Why?
|
| Cognition Disorders | 3 | 2011 | 985 | 0.140 |
Why?
|
| Functional Laterality | 5 | 2014 | 59 | 0.140 |
Why?
|
| Magnetoencephalography | 1 | 2017 | 2 | 0.140 |
Why?
|
| Brain Waves | 1 | 2016 | 4 | 0.140 |
Why?
|
| Electric Stimulation | 1 | 2016 | 51 | 0.130 |
Why?
|
| Brain | 3 | 2011 | 1649 | 0.130 |
Why?
|
| Young Adult | 5 | 2016 | 1994 | 0.130 |
Why?
|
| Dementia | 2 | 2012 | 560 | 0.130 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2016 | 49 | 0.120 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2016 | 79 | 0.120 |
Why?
|
| Neurosurgical Procedures | 1 | 2016 | 122 | 0.110 |
Why?
|
| Cognition | 2 | 2014 | 1339 | 0.110 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 1792 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 164 | 0.110 |
Why?
|
| Biomarkers | 2 | 2014 | 562 | 0.110 |
Why?
|
| Risk | 1 | 2014 | 204 | 0.110 |
Why?
|
| Axons | 1 | 2012 | 28 | 0.100 |
Why?
|
| Protein Subunits | 1 | 2011 | 18 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2011 | 42 | 0.090 |
Why?
|
| Middle Aged | 9 | 2018 | 8923 | 0.090 |
Why?
|
| Positron-Emission Tomography | 2 | 2010 | 87 | 0.090 |
Why?
|
| Headache | 1 | 2011 | 35 | 0.090 |
Why?
|
| Implantable Neurostimulators | 1 | 2010 | 5 | 0.090 |
Why?
|
| Seizures | 2 | 2023 | 67 | 0.090 |
Why?
|
| Frontal Lobe | 2 | 2011 | 81 | 0.080 |
Why?
|
| Neoplasms | 1 | 2010 | 237 | 0.070 |
Why?
|
| Analgesia, Epidural | 1 | 2007 | 54 | 0.070 |
Why?
|
| Verbal Learning | 2 | 2005 | 33 | 0.070 |
Why?
|
| Depression | 1 | 2011 | 444 | 0.070 |
Why?
|
| Pain | 1 | 2010 | 413 | 0.070 |
Why?
|
| Pain Measurement | 1 | 2007 | 483 | 0.060 |
Why?
|
| Parkinson Disease | 1 | 2012 | 670 | 0.060 |
Why?
|
| Adolescent | 3 | 2016 | 2172 | 0.060 |
Why?
|
| Pain, Postoperative | 1 | 2007 | 317 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2018 | 3538 | 0.050 |
Why?
|
| Proof of Concept Study | 1 | 2023 | 12 | 0.050 |
Why?
|
| Age Factors | 2 | 2018 | 766 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2018 | 3485 | 0.050 |
Why?
|
| Child | 2 | 2016 | 1295 | 0.050 |
Why?
|
| Animals | 3 | 2018 | 3642 | 0.050 |
Why?
|
| Peroxins | 2 | 2012 | 2 | 0.050 |
Why?
|
| Protein Transport | 2 | 2012 | 32 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2014 | 676 | 0.050 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2012 | 61 | 0.040 |
Why?
|
| Algorithms | 1 | 2023 | 350 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 420 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2019 | 19 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2019 | 31 | 0.040 |
Why?
|
| Reference Values | 3 | 2005 | 186 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2018 | 25 | 0.040 |
Why?
|
| Neuropsychological Tests | 2 | 2012 | 1196 | 0.040 |
Why?
|
| Action Potentials | 1 | 2018 | 86 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 219 | 0.040 |
Why?
|
| Mice | 2 | 2012 | 1395 | 0.030 |
Why?
|
| Malformations of Cortical Development, Group I | 1 | 2017 | 2 | 0.030 |
Why?
|
| Sensory Thresholds | 1 | 2016 | 22 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 64 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2016 | 117 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 599 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2016 | 641 | 0.030 |
Why?
|
| Internet | 1 | 2014 | 91 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 195 | 0.030 |
Why?
|
| Tissue Embedding | 1 | 2012 | 4 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 21 | 0.020 |
Why?
|
| Dentate Gyrus | 1 | 2012 | 6 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2012 | 18 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 44 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2012 | 51 | 0.020 |
Why?
|
| Transfection | 1 | 2012 | 121 | 0.020 |
Why?
|
| Valproic Acid | 1 | 2011 | 13 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 395 | 0.020 |
Why?
|
| Mental Status Schedule | 1 | 2011 | 90 | 0.020 |
Why?
|
| Sclerosis | 1 | 2011 | 66 | 0.020 |
Why?
|
| Age of Onset | 1 | 2011 | 94 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 139 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2011 | 56 | 0.020 |
Why?
|
| Radioisotopes | 1 | 2010 | 13 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2012 | 520 | 0.020 |
Why?
|
| Genetic Therapy | 1 | 2011 | 86 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2011 | 260 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2010 | 38 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 664 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2011 | 301 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 302 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2010 | 220 | 0.020 |
Why?
|
| Educational Status | 1 | 2011 | 293 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 415 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 891 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 879 | 0.020 |
Why?
|
| Incidence | 1 | 2007 | 759 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 105 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 348 | 0.010 |
Why?
|